These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 28558744

  • 21. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T, Aydın F, Nilüfer Tekgöz P, Sezer M, Uncu N, Çelikel Acar B.
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [Abstract] [Full Text] [Related]

  • 22. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients.
    Aybal Kutlugün A, Yildirim T, Altindal M, Arici M, Yasavul U, Turgan C.
    Ren Fail; 2010 Jul; 32(10):1230-2. PubMed ID: 20954987
    [Abstract] [Full Text] [Related]

  • 23. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
    Miyagawa I, Nakayamada S, Saito K, Hanami K, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.
    Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
    [Abstract] [Full Text] [Related]

  • 24. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
    Nadir H, Unver S, Ozel AM, Yazgan Y, Gultepe M, Evrenkaya TR, Demirturk L, Gurbuz AK.
    Ren Fail; 2007 May; 29(1):73-7. PubMed ID: 17365913
    [Abstract] [Full Text] [Related]

  • 25. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.
    Yilmaz S, Cinar M, Simsek I, Erdem H, Pay S.
    Rheumatology (Oxford); 2015 Mar; 54(3):564-5. PubMed ID: 25504961
    [No Abstract] [Full Text] [Related]

  • 26. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
    Imamura S, Narita S, Nishikomori R, Tsuruta H, Numakura K, Maeno A, Saito M, Inoue T, Tsuchiya N, Nanjo H, Heike T, Satoh S, Habuchi T.
    BMC Res Notes; 2016 Oct 19; 9(1):473. PubMed ID: 27760547
    [Abstract] [Full Text] [Related]

  • 27. A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever.
    Koga T, Sato S, Hagimori N, Yamamoto H, Ishimura M, Yasumi T, Kirino Y, Ikeda K, Yachie A, Migita K, Kishida D, Atsumi T, Kawakami A.
    Clin Exp Rheumatol; 2022 Sep 19; 40(8):1535-1542. PubMed ID: 36106542
    [Abstract] [Full Text] [Related]

  • 28. [Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy].
    Højberg AS, Mertz H.
    Ugeskr Laeger; 1995 Jul 10; 157(28):4035-7. PubMed ID: 7645081
    [Abstract] [Full Text] [Related]

  • 29. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
    Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, Sengul S, Keven K.
    Transplant Proc; 2019 Sep 10; 51(7):2292-2294. PubMed ID: 31400972
    [Abstract] [Full Text] [Related]

  • 30. An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.
    Koga T, Hagimori N, Sato S, Morimoto S, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A.
    Medicine (Baltimore); 2020 Jan 10; 99(1):e18328. PubMed ID: 31895769
    [Abstract] [Full Text] [Related]

  • 31. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
    Bozaci I, Tatar E.
    Int Urol Nephrol; 2021 Mar 10; 53(3):531-538. PubMed ID: 33058037
    [Abstract] [Full Text] [Related]

  • 32. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 33. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
    Peces R, Afonso S, Peces C, Nevado J, Selgas R.
    BMC Med Genet; 2017 Aug 31; 18(1):97. PubMed ID: 28859624
    [Abstract] [Full Text] [Related]

  • 34. Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever.
    Trabulus S, Korkmaz M, Kaya E, Seyahi N.
    Clin Transplant; 2018 Aug 31; 32(8):e13345. PubMed ID: 29981275
    [Abstract] [Full Text] [Related]

  • 35. Predictors of AA amyloidosis in familial Mediterranean fever.
    Mukhin NA, Kozlovskaya LV, Bogdanova MV, Rameev VV, Moiseev SV, Simonyan AKh.
    Rheumatol Int; 2015 Jul 31; 35(7):1257-61. PubMed ID: 25586652
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
    Alpay N, Sumnu A, Calışkan Y, Yazıcı H, Türkmen A, Gül A.
    Rheumatol Int; 2012 Oct 31; 32(10):3277-9. PubMed ID: 20386914
    [Abstract] [Full Text] [Related]

  • 37. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
    Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J.
    Nephrol Dial Transplant; 2009 Feb 31; 24(2):676-8. PubMed ID: 19033248
    [Abstract] [Full Text] [Related]

  • 38. Pulmonary amyloidosis in familial Mediterranean fever.
    Sahan C, Cengiz K.
    Acta Clin Belg; 2006 Feb 31; 61(3):147-51. PubMed ID: 16881565
    [Abstract] [Full Text] [Related]

  • 39. Secondary amyloidosis due to FMF.
    Yonem O, Bayraktar Y.
    Hepatogastroenterology; 2007 Jun 31; 54(76):1061-5. PubMed ID: 17629039
    [Abstract] [Full Text] [Related]

  • 40. [Familial Mediterranean fever: not to be missed].
    Frenkel J, Bemelman FJ, Potter van Loon BJ, Simon A.
    Ned Tijdschr Geneeskd; 2013 Jun 31; 157(18):A5784. PubMed ID: 23635502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.